<table id="_Refinv-148360b6-5d5b-4a93-92f9-f117601a" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 15. Summary of Drug Interactions With Lamotrigine</caption>
<col width="45%"></col>
<col width="36%"></col>
<col width="36%"></col>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Drug</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>Drug Plasma Concentration With Adjunctive Lamotrigine<footnote id="_Refid-3ec366cc-2f5d-4add-8789-04e1bd5b2">From adjunctive clinical trials and volunteer studies.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>Lamotrigine Plasma Concentration With Adjunctive Drugs<footnote id="_Refid-fd325348-007c-4aef-ad8f-bb181f819">Net effects were estimated by comparing the mean clearance values obtained in adjunctive clinical trials and volunteers studies.</footnote>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Oral contraceptives (e.g., ethinylestradiol/levonorgestrel)<footnote id="_Refid-807d4bd2-bacc-4782-a1db-84bca2a90">The effect of other hormonal contraceptive preparations or hormone replacement therapy on the pharmacokinetics of Lamotrigine has not been systematically evaluated in clinical trials, although the effect may be similar to that seen with the ethinylestradiol/levonorgestrel combinations.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔<footnote id="_Refid-65e27f2e-4ea0-46db-97ae-d3a8d0b99">Modest decrease in levonorgestrel.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↓</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Bupropion</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>Not assessed</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Carbamazepine (CBZ)</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↓</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>CBZ epoxide<footnote id="_Refid-35362309-3fde-4740-80c2-d6f329161">Not administered, but an active metabolite of carbamazepine.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>?</paragraph>
</td>
<td stylecode="Rrule "></td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Felbamate</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>Not assessed</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Gabapentin</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>Not assessed</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Levetiracetam</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Lithium</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>Not assessed</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Olanzapine</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔<footnote id="_Refid-ce24f0f1-c742-44cc-b474-edfffe783">Slight decrease, not expected to be clinically relevant.</footnote>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Oxcarbazepine</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>10-monohydroxy oxcarbazepine metabolite<footnote id="_Refid-9541bca3-6c27-4eb8-a6a5-b5d72d809">Not administered, but an active metabolite of oxcarbazepine.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td stylecode="Rrule "></td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Phenobarbital/primidone</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↓</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Phenytoin (PHT)</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↓</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Pregabalin</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Rifampin</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>Not assessed</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↓</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Topiramate</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔<footnote id="_Refid-9bb9ddde-3f53-4113-95da-ea72603e1">Slight increase not expected to be clinically relevant.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Valproate</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↓</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↑</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Valproate + PHT and/or CBZ</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>Not assessed</paragraph>
</td>
<td align="center" stylecode="Rrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Zonisamide</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>Not assessed</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>↔</paragraph>
</td>
</tr>
<tr>
<td colspan="3" stylecode="Botrule ">
<paragraph>↔ = No significant effect.<br/>? = Conflicting data.</paragraph>
</td>
</tr>
</tbody>
</table>